Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin Zhang

Showing results (341-350 of 373) with videos related to

Pageof 38
Sort By:
Cancer Communications (London, England)|January 5, 2019
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancerXiuwen Guan, Fei Ma, Chunxiao Li, et al.
Frontiers in Oncology|May 28, 2021
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han PopulationShaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Breast Cancer Research and Treatment|October 14, 2021
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-upFangchao Zheng, Feng Du, Wenmiao Wang, et al.
Breast (Edinburgh, Scotland)|August 25, 2020
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in ChinaShaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Breast (Edinburgh, Scotland)|January 7, 2022
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, ChinaYiqun Li, Hongnan Mo, Xiuwen Guan, et al.
Frontiers in Oncology|February 3, 2022
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, ChinaYiqun Li, Nilupai Abudureheiyimu, Hongnan Mo, et al.
Plos One|July 19, 2014
A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancerCan Zhou, Jian jun He, Jing Li, et al.
Molecules (Basel, Switzerland)|March 24, 2016
Rhubarb Anthraquinones Protect Rats against Mercuric Chloride (HgCl₂)-Induced Acute Renal FailureDan Gao, Ling-Na Zeng, Pin Zhang, et al.
Breast Cancer Research : BCR|February 20, 2026
Prognostic value of Ki-67 index in malignant phyllodes tumor of the breast: a multi-center real-world studyYiran Zhou, Changyuan Guo, Yan Wang, et al.
Breast (Edinburgh, Scotland)|December 14, 2020
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Qiao Li, Hongnan Mo, et al.
Pageof 38

Showing results (341-350 of 373) with videos related to

Sort By:
Pageof 38
Cancer Communications (London, England)|January 5, 2019
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancerXiuwen Guan, Fei Ma, Chunxiao Li, et al.
Frontiers in Oncology|May 28, 2021
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han PopulationShaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Breast Cancer Research and Treatment|October 14, 2021
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-upFangchao Zheng, Feng Du, Wenmiao Wang, et al.
Breast (Edinburgh, Scotland)|August 25, 2020
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in ChinaShaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Breast (Edinburgh, Scotland)|January 7, 2022
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, ChinaYiqun Li, Hongnan Mo, Xiuwen Guan, et al.
Frontiers in Oncology|February 3, 2022
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, ChinaYiqun Li, Nilupai Abudureheiyimu, Hongnan Mo, et al.
Plos One|July 19, 2014
A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancerCan Zhou, Jian jun He, Jing Li, et al.
Molecules (Basel, Switzerland)|March 24, 2016
Rhubarb Anthraquinones Protect Rats against Mercuric Chloride (HgCl₂)-Induced Acute Renal FailureDan Gao, Ling-Na Zeng, Pin Zhang, et al.
Breast Cancer Research : BCR|February 20, 2026
Prognostic value of Ki-67 index in malignant phyllodes tumor of the breast: a multi-center real-world studyYiran Zhou, Changyuan Guo, Yan Wang, et al.
Breast (Edinburgh, Scotland)|December 14, 2020
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Qiao Li, Hongnan Mo, et al.
Pageof 38